Aysel Kocagul-Celikbas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aysel Kocagul-Celikbas has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Derya Yapar
Department of Infectious Diseases and Clinical Microbiology, Hitit University School of Medicine, Çorum, Turkey
7 shared publications - Nurcan Baykam
Department of Infectious Diseases and Clinical Microbiology, Hitit University School of Medicine, Çorum, Turkey
6 shared publications - Ozlem Akdogan
Department of Infectious Diseases and Clinical Microbiology, Hitit University Faculty of Medicine, Çorum, Türkiye
5 shared publications - Neşe Demirtürk
Afyonkarahisar Sağlık Bilimleri Üniversitesi
4 shared publications - Alpay Azap
Department of Infectious Diseases and Clinical Microbiology, Ankara University Faculty of Medicine, Ankara, Turkey
3 shared publications - Aysun Benli
Department of Infectious Diseases and Clinical Microbiology, İstanbul Faculty of Medicine, İstanbul University, İstanbul 34093, Türkiye
3 shared publications
Latest Publications
- 14 February 2026
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
Correction to: The Turkish Clinical Microbiology and Infectious Diseases Society (KLİMİK) Evidence-Based Guideline for the Diagnosis and Treatment of Brucellosis, 2023
CORRECTION NOTE Two corrections have been made to the original version of this article, published on February 2, 2023: In Table 3, the information ‘DOX tablet 200 mg/day, single dose, oral +’ under the headings 1)Infective Endocarditis associated with Brucella spp. and 2) Neurobrucellosis has been corrected to: ‘DOX tablet 200 mg/day, 2 doses, oral +’. Corrected article: https://doi.org/10.36519/kd.2023.4576
- 14 February 2026
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
Correction to: The Turkish Clinical Microbiology and Infectious Diseases Society (KLİMİK) Evidence-Based Guideline for the Diagnosis and Treatment of Brucellosis, 2023
CORRECTION NOTE Two corrections have been made to the original version of this article, published on February 2, 2023: In Table 3, the information ‘DOX tablet 200 mg/day, single dose, oral +’ under the headings 1)Infective Endocarditis associated with Brucella spp. and 2) Neurobrucellosis has been corrected to: ‘DOX tablet 200 mg/day, 2 doses, oral +’. Corrected article: https://doi.org/10.36519/kd.2023.4576
- Open Access
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 29 (3) , 111-117
A Systematic Review and Analysis of Brucella Endocarditis Cases
Endocarditis is the most common cause of death from brucellosis. The information used to guide the management of cases with Brucella endocarditis has relied on case reports/series. Risk factors related to death and other adverse outcomes in patients with Brucella endocarditis were identified by an individual-patient data analysis of all reported Brucella endocarditis cases in the literature. The keywords “Bruce” and “endocard” were used to search articles published until July 2022 on PubMed and ULAKBIM databases. Case reports/series containing patients with endocarditis caused by Brucella spp., aged ≥17 years, and with data on antimicrobial or surgical treatment were included in the study. Epidemiological, clinical, laboratory, and treatment characteristics and outcomes of 273 cases from 86 eligible articles were recorded. It was found that male gender, a Wright serum tube agglutination (STA) titer of ≥1/1280 on admission, development of heart failure due to endocarditis were independent risk factors that increase mortality, while the usage of aminoglycoside and cardiac surgical intervention for endocarditis were factors reducing mortality. Including streptomycin or gentamicin in the treatment regimen may benefit patients with Brucella endocarditis. Valve surgery could be life-saving in patients with Brucella endocarditis. An STA titer of ≥1/1280, which probably reflects long-term and advanced disease, may be used as a marker for increased mortality. However, additional and more reliable studies are needed to define the most appropriate management approach in diagnosing and treating cases with Brucella endocarditis due to the low quality of the current evidence.
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 29 (3) , 111-117
Open AccessA Systematic Review and Analysis of Brucella Endocarditis Cases
Endocarditis is the most common cause of death from brucellosis. The information used to guide the management of cases with Brucella endocarditis has relied on case reports/series. Risk factors related to death and other adverse outcomes in patients with Brucella endocarditis were identified by an individual-patient data analysis of all reported Brucella endocarditis cases in the literature. The keywords “Bruce” and “endocard” were used to search articles published until July 2022 on PubMed and ULAKBIM databases. Case reports/series containing patients with endocarditis caused by Brucella spp., aged ≥17 years, and with data on antimicrobial or surgical treatment were included in the study. Epidemiological, clinical, laboratory, and treatment characteristics and outcomes of 273 cases from 86 eligible articles were recorded. It was found that male gender, a Wright serum tube agglutination (STA) titer of ≥1/1280 on admission, development of heart failure due to endocarditis were independent risk factors that increase mortality, while the usage of aminoglycoside and cardiac surgical intervention for endocarditis were factors reducing mortality. Including streptomycin or gentamicin in the treatment regimen may benefit patients with Brucella endocarditis. Valve surgery could be life-saving in patients with Brucella endocarditis. An STA titer of ≥1/1280, which probably reflects long-term and advanced disease, may be used as a marker for increased mortality. However, additional and more reliable studies are needed to define the most appropriate management approach in diagnosing and treating cases with Brucella endocarditis due to the low quality of the current evidence.
- Open Access
- 26 September 2024
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 6 (3) , 216-224
The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data
In 75-85% of cases of acute hepatitis C infection, the disease becomes chronic and carries a risk of developing liver failure and hepatocellular cancer. In its global hepatitis report published in 2017, the World Health Organization (WHO) reported that 71.1 (95% uncertainty interval [UI]: 62.1-79.0 million) million people were chronically infected with the hepatitis C virus
- 26 September 2024
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 6 (3) , 216-224
Open AccessThe Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data
In 75-85% of cases of acute hepatitis C infection, the disease becomes chronic and carries a risk of developing liver failure and hepatocellular cancer. In its global hepatitis report published in 2017, the World Health Organization (WHO) reported that 71.1 (95% uncertainty interval [UI]: 62.1-79.0 million) million people were chronically infected with the hepatitis C virus
- Open Access
- 30 June 2023
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 36 (2) , 86-123
The Turkish Clinical Microbiology and Infectious Diseases Society (KLİMİK) Evidence-Based Guideline for the Diagnosis and Treatment of Brucellosis, 2023
Although brucellosis is very common in the world and Türkiye, there are no evidence-based guidelines to guide the diagnosis and treatment of the disease. This guide has been prepared by the Turkish Society of Clinical Microbiology and Infectious Diseases to provide evidence-based recommendations to physicians from different specialties interested in the diagnosis and treatment of brucellosis. The recommendations of the Clinical Practice Guide Development Guide of the Infectious Diseases Society of America (IDSA) were taken as the basis for preparing this guide. The guideline preparation group determined 20 questions considered to be important in the diagnosis and treatment of brucellosis, and the publications that could answer these questions prepared in PICO (Population/Patient [P], Intervention [I], Comparison [C], Outcome [O]) format, were searched in ULAKBİM Tr Dizin, PubMed, Cochrane databases without date restrictions. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) Working Group method was used to rank the evidence and determine the strength of the recommendations for each PICO question and for each individual outcome. Meta-analyses of comparative clinical studies were performed to answer the PICO questions. Individual participant data (IPD) meta-analyses with data obtained from case reports and case series were conducted in the absence of comparative clinical studies. It is planned to update the recommendations at regular intervals in line with the results of new studies.
- 30 June 2023
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 36 (2) , 86-123
Open AccessThe Turkish Clinical Microbiology and Infectious Diseases Society (KLİMİK) Evidence-Based Guideline for the Diagnosis and Treatment of Brucellosis, 2023
Although brucellosis is very common in the world and Türkiye, there are no evidence-based guidelines to guide the diagnosis and treatment of the disease. This guide has been prepared by the Turkish Society of Clinical Microbiology and Infectious Diseases to provide evidence-based recommendations to physicians from different specialties interested in the diagnosis and treatment of brucellosis. The recommendations of the Clinical Practice Guide Development Guide of the Infectious Diseases Society of America (IDSA) were taken as the basis for preparing this guide. The guideline preparation group determined 20 questions considered to be important in the diagnosis and treatment of brucellosis, and the publications that could answer these questions prepared in PICO (Population/Patient [P], Intervention [I], Comparison [C], Outcome [O]) format, were searched in ULAKBİM Tr Dizin, PubMed, Cochrane databases without date restrictions. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) Working Group method was used to rank the evidence and determine the strength of the recommendations for each PICO question and for each individual outcome. Meta-analyses of comparative clinical studies were performed to answer the PICO questions. Individual participant data (IPD) meta-analyses with data obtained from case reports and case series were conducted in the absence of comparative clinical studies. It is planned to update the recommendations at regular intervals in line with the results of new studies.
- Open Access
- 21 December 2022
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 4 (4) , 285-288
A Rare Presentation of Leptospirosis: Dysarthria and Guillain-Barré Syndrome
Leptospirosis can present with severe cases such as polymyositis, peripheral neuropathy, and rarely, Guillain-Barré Syndrome (GBS). This paper reports a case who presented with dysarthria and GBS. A female patient presented with complaints of weakness, dizziness, diarrhea, and dysarthric. Her assessments included muscle strength globally 4/5 and deep tendon reflexes as hypoactive. An electromyographic examination was performed with the increase of weakness in the lower extremities, which indicated findings compatible with GBS. Antibodies against Leptospira biflexa serovar Patoc 1 at 1/400 titer were detected in the microscopic agglutination test (MAT). Neurological involvement in leptospirosis cases can range from meningoencephalitis to GBS. Keywords: dysarthria, Guillain-Barré syndrome, leptospirosis, acute kidney failure
- 21 December 2022
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 4 (4) , 285-288
Open AccessA Rare Presentation of Leptospirosis: Dysarthria and Guillain-Barré Syndrome
Leptospirosis can present with severe cases such as polymyositis, peripheral neuropathy, and rarely, Guillain-Barré Syndrome (GBS). This paper reports a case who presented with dysarthria and GBS. A female patient presented with complaints of weakness, dizziness, diarrhea, and dysarthric. Her assessments included muscle strength globally 4/5 and deep tendon reflexes as hypoactive. An electromyographic examination was performed with the increase of weakness in the lower extremities, which indicated findings compatible with GBS. Antibodies against Leptospira biflexa serovar Patoc 1 at 1/400 titer were detected in the microscopic agglutination test (MAT). Neurological involvement in leptospirosis cases can range from meningoencephalitis to GBS. Keywords: dysarthria, Guillain-Barré syndrome, leptospirosis, acute kidney failure
- Open Access
- 21 December 2022
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 4 (4) , 274-279
Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy
Objective: Percutaneous transhepatic cholangiography (PTC) is an invasive procedure used in patients with obstructive jaundice in the progress of some malignancies, and its most common complication is infection. We aimed to evaluate the patients who underwent PTC regarding their cultures, prophylaxis, and antibiotics used for treatment. Materials and Methods: In this cross-sectional study, patients who underwent PTC and were followed up in a medical oncology outpatient clinic between 2010-2017 were evaluated retrospectively. Patients’ data were obtained from the hospital record system (FONET), epicrisis forms, and patient progress files. Results: A total of 93 patients were included in the study. Prophylaxis was given in 50% of the cases. Complications developed in 68% of the cases after the intervention, and the infectious disease clinic consulted all. Blood cultures were obtained from 89% of the febrile patients; however, bile cultures were obtained only from 29%. The rate of resistant Gram-negative enteric bacteria in growing microorganisms was 52% (n=13). It was determined that 65% of the initiated empirical treatments were appropriate for the growth of microorganisms. Conclusion: The growth rate was significantly higher in blood cultures than in bile cultures. The lower growth rate in bile culture was attributed to the low number of bile cultures. There was no significant difference regarding the growth rate and drug resistance of the microorganisms. Therefore, we think giving antibiotics as treatment rather than prophylaxis is more appropriate. Taking cultures will ensure that patients receive appropriate antibiotic therapy for the causative agent. Keywords: Antibiotic prophylaxis, bacteremia, biliary tract infections, percutaneous transhepatic cholangiography
- 21 December 2022
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 4 (4) , 274-279
Open AccessEvaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy
Objective: Percutaneous transhepatic cholangiography (PTC) is an invasive procedure used in patients with obstructive jaundice in the progress of some malignancies, and its most common complication is infection. We aimed to evaluate the patients who underwent PTC regarding their cultures, prophylaxis, and antibiotics used for treatment. Materials and Methods: In this cross-sectional study, patients who underwent PTC and were followed up in a medical oncology outpatient clinic between 2010-2017 were evaluated retrospectively. Patients’ data were obtained from the hospital record system (FONET), epicrisis forms, and patient progress files. Results: A total of 93 patients were included in the study. Prophylaxis was given in 50% of the cases. Complications developed in 68% of the cases after the intervention, and the infectious disease clinic consulted all. Blood cultures were obtained from 89% of the febrile patients; however, bile cultures were obtained only from 29%. The rate of resistant Gram-negative enteric bacteria in growing microorganisms was 52% (n=13). It was determined that 65% of the initiated empirical treatments were appropriate for the growth of microorganisms. Conclusion: The growth rate was significantly higher in blood cultures than in bile cultures. The lower growth rate in bile culture was attributed to the low number of bile cultures. There was no significant difference regarding the growth rate and drug resistance of the microorganisms. Therefore, we think giving antibiotics as treatment rather than prophylaxis is more appropriate. Taking cultures will ensure that patients receive appropriate antibiotic therapy for the causative agent. Keywords: Antibiotic prophylaxis, bacteremia, biliary tract infections, percutaneous transhepatic cholangiography
- 28 March 2022
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 35 (1) , 40-45
Are We Ready to Follow HIV/AIDS Patients?
Objective: There is an increase in the number of HIV/AIDS cases in our city, which is parallel to the increase in our country. We started to follow HIV/AIDS cases in our center last year, and we conducted a survey to evaluate the knowledge level and attitudes of physicians and nurses working in our hospital about HIV/AIDS, and the survey results were evaluated. Methods: A questionnaire consisting of 25 questions covering the demographic characteristics of the participants and measuring the level of knowledge about HIV/AIDS was applied. Results:120 physicians and nurses with a mean age of 35.28±8.58 participated in the survey. 62.5% were women. 55% were physicians, 45% nurses, 58.3% from internal medicine, 38.3% were surgical branches, and 3.3% were from basic sciences. All healthcare workers knew that HIV was transmitted through sexual contact and blood, and 99.2% with the use of shared injectors. 65% of the participants knew that HIV could be transmitted by breast milk, but 45.8% thought it could be transmitted by kissing. 45% of the participants, most of which were nurses, thought that the disease had no cure (p=0.001). 82.5% were aware of the increase in HIV cases in the country, and 56.7% thought that there was also an increase in our city. Although participants wanted these cases to be followed in our hospital (75.8%) and thought that prejudiced behavior was wrong (89.2%), they did not want to be included in the care of these patients (73%) due to the fear of contagion. They thought that it would be appropriate to follow them only in the Infectious Diseases clinic (60.8%). Conclusions: Even if they are not fully aware of it, healthcare professionals approach HIV/AIDS cases with prejudice. One of the reasons for this is the lack of knowledge about the disease. Lack of knowledge brings along discrimination and stigmatization. In-service training programs are needed to overcome this situation.
- 28 March 2022
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 35 (1) , 40-45
Are We Ready to Follow HIV/AIDS Patients?
Objective: There is an increase in the number of HIV/AIDS cases in our city, which is parallel to the increase in our country. We started to follow HIV/AIDS cases in our center last year, and we conducted a survey to evaluate the knowledge level and attitudes of physicians and nurses working in our hospital about HIV/AIDS, and the survey results were evaluated. Methods: A questionnaire consisting of 25 questions covering the demographic characteristics of the participants and measuring the level of knowledge about HIV/AIDS was applied. Results:120 physicians and nurses with a mean age of 35.28±8.58 participated in the survey. 62.5% were women. 55% were physicians, 45% nurses, 58.3% from internal medicine, 38.3% were surgical branches, and 3.3% were from basic sciences. All healthcare workers knew that HIV was transmitted through sexual contact and blood, and 99.2% with the use of shared injectors. 65% of the participants knew that HIV could be transmitted by breast milk, but 45.8% thought it could be transmitted by kissing. 45% of the participants, most of which were nurses, thought that the disease had no cure (p=0.001). 82.5% were aware of the increase in HIV cases in the country, and 56.7% thought that there was also an increase in our city. Although participants wanted these cases to be followed in our hospital (75.8%) and thought that prejudiced behavior was wrong (89.2%), they did not want to be included in the care of these patients (73%) due to the fear of contagion. They thought that it would be appropriate to follow them only in the Infectious Diseases clinic (60.8%). Conclusions: Even if they are not fully aware of it, healthcare professionals approach HIV/AIDS cases with prejudice. One of the reasons for this is the lack of knowledge about the disease. Lack of knowledge brings along discrimination and stigmatization. In-service training programs are needed to overcome this situation.
- 24 March 2022
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 3 (1) , 55-60
Comparison of pulmonary involvement due to COVID-19 infection in patients with ankylosing spondylitis using sulfasalazine and biologic agents
Amaç: Bu çalışmanın amacı, ankilozan spondilit tanılı sülfasalazin ve biyolojik ilaç kullanan hastalarda SARS CoV-2 faktörünün neden olduğu akciğer tutulumunu incelemek. Gereç ve Yöntem: COVID-19 geçirmiş RT-PCR pozitif AS tanısı olan ve en az bir yıldır hastanemizde takibi olan hastaların dosya sistemleri retrospektif olarak gözden geçirildi. AS tanısı alan hastalar sülfasalazin ve biyolojik ajan kullananlar olarak iki gruba ayrıldı. Hastaların toraks bilgisayarlı tomografi (BT) sonuçları hafif, orta, şiddetli, iki taraflı ve tek taraflı olarak ayrıldı. Veriler ayrıca hasta ve kontrol grupları arasında karşılaştırıldı. Bulgular: Çalışmaya alınan 58 hastanın 26’sı biyolojik ajan, 32’si sülfasalazin alıyordu. DMARD kullanan hastalardan 17’si adalimumab, 4’ü etanercept, 2’si golimumab, 2’si sertolizumab ve 1’i infliximab kullanıyordu. AS grubundaki 13 hastada toraks bilgisayarlı tomografisinde SARS CoV-2 nedeniyle akciğer tutulumu vardı. 9’u erkek, 4’ü kadın olan hastaların COVID-19 nedeniyle hastaneye yatırıldığı görüldü. 10 hastada her iki akciğerde de COVID-19’a bağlı tutulum saptandı. Sonuç: otoimmün ve inflamatuar romatizmal hastalıklarda kullanılan immünomodülatör tedavilerin COVID-19 seyrini olumlu ya da olumsuz etkileyeceği henüz bilinmemektedir. Bizim çalışmamızda sulfasalazin ve biyolojik ajan kullanan AS tanılı hastalarda COVID-19 hafif semptomlarla seyretmiştir.
- 24 March 2022
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 3 (1) , 55-60
Comparison of pulmonary involvement due to COVID-19 infection in patients with ankylosing spondylitis using sulfasalazine and biologic agents
Amaç: Bu çalışmanın amacı, ankilozan spondilit tanılı sülfasalazin ve biyolojik ilaç kullanan hastalarda SARS CoV-2 faktörünün neden olduğu akciğer tutulumunu incelemek. Gereç ve Yöntem: COVID-19 geçirmiş RT-PCR pozitif AS tanısı olan ve en az bir yıldır hastanemizde takibi olan hastaların dosya sistemleri retrospektif olarak gözden geçirildi. AS tanısı alan hastalar sülfasalazin ve biyolojik ajan kullananlar olarak iki gruba ayrıldı. Hastaların toraks bilgisayarlı tomografi (BT) sonuçları hafif, orta, şiddetli, iki taraflı ve tek taraflı olarak ayrıldı. Veriler ayrıca hasta ve kontrol grupları arasında karşılaştırıldı. Bulgular: Çalışmaya alınan 58 hastanın 26’sı biyolojik ajan, 32’si sülfasalazin alıyordu. DMARD kullanan hastalardan 17’si adalimumab, 4’ü etanercept, 2’si golimumab, 2’si sertolizumab ve 1’i infliximab kullanıyordu. AS grubundaki 13 hastada toraks bilgisayarlı tomografisinde SARS CoV-2 nedeniyle akciğer tutulumu vardı. 9’u erkek, 4’ü kadın olan hastaların COVID-19 nedeniyle hastaneye yatırıldığı görüldü. 10 hastada her iki akciğerde de COVID-19’a bağlı tutulum saptandı. Sonuç: otoimmün ve inflamatuar romatizmal hastalıklarda kullanılan immünomodülatör tedavilerin COVID-19 seyrini olumlu ya da olumsuz etkileyeceği henüz bilinmemektedir. Bizim çalışmamızda sulfasalazin ve biyolojik ajan kullanan AS tanılı hastalarda COVID-19 hafif semptomlarla seyretmiştir.
- Open Access
- 14 February 2022
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 4 (1) , 1-6
COVID-19 and Crimean-Congo Hemorrhagic Fever: Is there any Similarity in Chest Radiology?
Objective: While the coronavirus disease 2019 (COVID-19) pandemic was continuing at full speed, patients with Crimean-Congo hemorrhagic fever (CCHF), which is endemic in our region, apply to the emergency department simultaneously. The presence of computed tomography (CT) lesions suggesting COVID-19 in some CCHF patients has brought to our mind the question of whether there is CCHF lung involvement even though respiratory symptoms are not at the forefront. Methods: In this study, the findings of chest CT, demographic data and clinical symptoms of cases who had thorax tomography scan with suspicion of COVID-19 in the emergency department in the spring and summer of 2020 and were diagnosed with CCHF as a result of the evaluation and followed up in our clinic were compared with the findings of COVID-19 cases that were hospitalized and treated in the same period. Results: Seventy-seven COVID-19 and 25 CCHF cases were included in the study. Myalgia, headache, diarrhea, nausea and vomiting were significantly higher in CCHF patients (p p= 0.034). Ground-glass opacity (GGO) was the most common tomography finding in CCHF, and cases without lung involvement were significantly higher (p = 0.001). GGO, consolidation, vascularization, atelectasis band, reverse halo, air-bubble, nodule were significantly high in COVID-19 patients. Conclusion: During the epidemic period, no pathological finding was found in thoracic CT in most of the CCHF cases, and the presence of involvement in the lung tomography in cases with similar clinical and laboratory findings should primarily suggest the diagnosis of COVID-19. Keywords: coronavirus disease 2019, COVID-19, Crimean-Congo hemorrhagic fever (CCHF), computed tomography (CT), ground-glass opacity (GGO)
- 14 February 2022
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 4 (1) , 1-6
Open AccessCOVID-19 and Crimean-Congo Hemorrhagic Fever: Is there any Similarity in Chest Radiology?
Objective: While the coronavirus disease 2019 (COVID-19) pandemic was continuing at full speed, patients with Crimean-Congo hemorrhagic fever (CCHF), which is endemic in our region, apply to the emergency department simultaneously. The presence of computed tomography (CT) lesions suggesting COVID-19 in some CCHF patients has brought to our mind the question of whether there is CCHF lung involvement even though respiratory symptoms are not at the forefront. Methods: In this study, the findings of chest CT, demographic data and clinical symptoms of cases who had thorax tomography scan with suspicion of COVID-19 in the emergency department in the spring and summer of 2020 and were diagnosed with CCHF as a result of the evaluation and followed up in our clinic were compared with the findings of COVID-19 cases that were hospitalized and treated in the same period. Results: Seventy-seven COVID-19 and 25 CCHF cases were included in the study. Myalgia, headache, diarrhea, nausea and vomiting were significantly higher in CCHF patients (p p= 0.034). Ground-glass opacity (GGO) was the most common tomography finding in CCHF, and cases without lung involvement were significantly higher (p = 0.001). GGO, consolidation, vascularization, atelectasis band, reverse halo, air-bubble, nodule were significantly high in COVID-19 patients. Conclusion: During the epidemic period, no pathological finding was found in thoracic CT in most of the CCHF cases, and the presence of involvement in the lung tomography in cases with similar clinical and laboratory findings should primarily suggest the diagnosis of COVID-19. Keywords: coronavirus disease 2019, COVID-19, Crimean-Congo hemorrhagic fever (CCHF), computed tomography (CT), ground-glass opacity (GGO)
- Open Access
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (4) , 880-887
Remdesivir treatment for patients with moderate to severe COVID-19
Background/aim: Remdesivir, which was first developed for the treatment of Ebola disease but failed to meet expectations, has become hope in the fight against the COVID-19 pandemic. This study aimed to evaluate risk factors for mortality and prognosis of adult moderate/severe COVID-19 patients treated with remdesivir, and safety and tolerability of 5 days of remdesivir treatment. Materials and methods: This multicenter prospective observational study was conducted in 14 centers in Turkey. Pregnancy or breastfeeding, multiorgan failure, or usage of vasopressors for septic shock, ALT > 5 × the upper limit of the normal range, or eGRF
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (4) , 880-887
Open AccessRemdesivir treatment for patients with moderate to severe COVID-19
Background/aim: Remdesivir, which was first developed for the treatment of Ebola disease but failed to meet expectations, has become hope in the fight against the COVID-19 pandemic. This study aimed to evaluate risk factors for mortality and prognosis of adult moderate/severe COVID-19 patients treated with remdesivir, and safety and tolerability of 5 days of remdesivir treatment. Materials and methods: This multicenter prospective observational study was conducted in 14 centers in Turkey. Pregnancy or breastfeeding, multiorgan failure, or usage of vasopressors for septic shock, ALT > 5 × the upper limit of the normal range, or eGRF